News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nymox Pharmaceutical (NYMX) Reports First Quarter 2014 Financial Results


5/15/2014 11:50:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HASBROUCK HEIGHTS, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the first quarter of 2014. Nymox reported a net loss of $2,592,816, or $0.07 per share for the quarter ended March 31, 2014, compared to $1,093,906, or $0.03 per share for the quarter ended March 31, 2013. The increase in net loss is due to stock compensation charges of $1,420,185 in 2014 compared to $26,640 in 2013. - See more at: http://www.globenewswire.com/news-release/2014/05/15/636856/10081946/en/Nymox-Reports-First-Quarter-2014-Financial-Results.html#sthash.UWA70dKJ.dpuf

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES